Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Biodesix (BDSX) over the last 6 years, with Q3 2025 value amounting to $150000.0.

  • Biodesix's Non-cash Items fell 9127.4% to $150000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $150000.0, marking a year-over-year decrease of 9127.4%. This contributed to the annual value of $719000.0 for FY2024, which is 4460.71% down from last year.
  • Latest data reveals that Biodesix reported Non-cash Items of $150000.0 as of Q3 2025, which was down 9127.4% from $2.8 million recorded in Q2 2025.
  • Biodesix's 5-year Non-cash Items high stood at $20.8 million for Q2 2021, and its period low was $150000.0 during Q3 2025.
  • Over the past 5 years, Biodesix's median Non-cash Items value was $1.3 million (recorded in 2021), while the average stood at $2.6 million.
  • In the last 5 years, Biodesix's Non-cash Items soared by 67872.0% in 2021 and then plummeted by 9474.19% in 2022.
  • Biodesix's Non-cash Items (Quarter) stood at $6.3 million in 2021, then tumbled by 76.32% to $1.5 million in 2022, then crashed by 35.26% to $964000.0 in 2023, then fell by 25.41% to $719000.0 in 2024, then plummeted by 79.14% to $150000.0 in 2025.
  • Its Non-cash Items was $150000.0 in Q3 2025, compared to $2.8 million in Q2 2025 and $2.4 million in Q1 2025.